Expo Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.95 Cr
as on 10-12-2024
- Paid Up Capital ₹ 2.89 Cr
as on 10-12-2024
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 60.05%
(FY 2023)
- Profit 33.50%
(FY 2023)
- Ebitda 243.61%
(FY 2023)
- Net Worth 0.52%
(FY 2023)
- Total Assets 1.37%
(FY 2023)
About Expo Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.95 Cr and a paid-up capital of Rs 2.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Damburu Panda, Sriram Panda, and Sabita Devi serve as directors at the Company.
- CIN/LLPIN
U01135OR1994PLC003709
- Company No.
003709
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Sep 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Expo Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sriram Panda  | Managing Director | 02-Aug-2010 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Damburu Panda | Director | 19-Sep-1994 | Current |
| Sabita Devi | Director | 06-Jul-2011 | Current |
Financial Performance of Expo Biotech.
Expo Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.05% increase. The company also saw a substantial improvement in profitability, with a 33.5% increase in profit. The company's net worth moved up by a moderate rise of 0.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Expo Biotech?
In 2023, Expo Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mits Innovation Research And Consultancy Private LimitedActive 13 years 1 monthSriram Panda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Expo Biotech?
Unlock and access historical data on people associated with Expo Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Expo Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Expo Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
